10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 65,080 | 0 |
| Receivables | 0 | 0 | 0 | 28,088 | 0 |
| Inventories | 0 | 0 | 0 | 8,570 | 0 |
| Other current assets | 0 | 0 | 0 | 4,498 | 0 |
| TOTAL | $0 | $0 | $0 | $106,236 | $0 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 25,210 | N/A |
| Other Non-Current Assets | 0 | 0 | 0 | 6,947 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $32,157 | $N/A |
| Total Assets | $0 | $0 | $0 | $124,310 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 4,187 | 0 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 8,792 | 0 |
| Accrued Expenses | 0 | 0 | 0 | 16,988 | 0 |
| Other current liabilities | 0 | 0 | 0 | 2,395 | 0 |
| TOTAL | $0 | $0 | $0 | $32,362 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 0 | 25,489 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 38,771 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $68,691 | $N/A |
| Total Liabilities | $0 | $0 | $0 | $101,053 | $0 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 0 | 1 | 0 |
| Retained earnings | 0 | 0 | 0 | -231,116 | 0 |
| Other shareholders' equity | 0 | 0 | 0 | 243,207 | 0 |
| TOTAL | $0 | $0 | $0 | $23,257 | $0 |
| Total Liabilities And Equity | $0 | $0 | $0 | $124,310 | $0 |